racemetirosine has been researched along with Binge Eating in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Homan, P | 1 |
| Grob, S | 1 |
| Milos, G | 1 |
| Schnyder, U | 1 |
| Hasler, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neuronal Correlates of Catecholamine Depletion in Patients With Bulimia Nervosa Off Medication and Healthy Controls[NCT02179814] | 60 participants (Anticipated) | Interventional | 2012-02-20 | Suspended (stopped due to Conduct of the first analyses) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for racemetirosine and Binge Eating
| Article | Year |
|---|---|
Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptoms.
Topics: Adult; alpha-Methyltyrosine; Body Mass Index; Bulimia; Catecholamines; Convalescence; Cross-Over Stu | 2013 |